CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock At Cost [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings (Accumulated Deficit) [Member]	Total
Balance at Feb. 01, 2020	$ 32	$ 345,102	$ (230,169)	$ (1,479)	$ (108,971)	$ 4,515
Balance (in shares) at Feb. 01, 2020	3,226		(1,409)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ 0	0	$ 0	0	(3,892)	(3,892)
Pension actuarial gain (loss) adjustment	0	0	0	(528)	0	(528)
Issuance of warrants	0	836	0	0	0	836
Vested restricted shares	$ 0	(9)	$ 0	0	0	(9)
Vested restricted shares (in shares)	4		(1)
Common stock issued- Director grants	$ 0	243	$ 0	0	0	243
Common stock issued- Director (in shares)	6		0
Exercise of warrants	$ 1	0	$ 0	0	0	1
Exercise of warrants (in shares)	101		0
Amortization of unearned compensation/restricted stock amortization	$ 0	323	$ 0	0	0	323
Balance at Jan. 30, 2021	$ 33	346,495	$ (230,169)	(2,007)	(112,863)	1,489
Balance (in shares) at Jan. 30, 2021	3,337		(1,410)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ 0	0	$ 0	0	(8,031)	(8,031)
Pension actuarial gain (loss) adjustment	0	0	0	1,097	0	1,097
Common stock issued- Director grants	$ 0	184	$ 0	0	0	184
Common stock issued- Director (in shares)	9		0
Exercise of warrants	$ 2	0	$ (1)	0	0	1
Exercise of warrants (in shares)	138		0
Exercise of stock options	$ 0	51	$ 0	0	0	51
Exercise of stock options (in shares)	2		0
Amortization of unearned compensation/restricted stock amortization	$ 0	263	$ 0	0	0	263
Sale of shares, net of expenses	$ 4	12,227	$ 0	0	0	12,231
Sale of shares, net of expenses (in shares)	417		0
Balance at Jan. 29, 2022	$ 39	$ 359,220	$ (230,170)	$ (910)	$ (120,894)	$ 7,285
Balance (in shares) at Jan. 29, 2022	3,903		(1,410)